Back to Search
Start Over
Caveat mammalian target of rapamycin (mTOR) revisited: Neurofibromatosis.
- Source :
-
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 Apr; Vol. 88 (4), pp. 790-791. Date of Electronic Publication: 2023 Feb 28. - Publication Year :
- 2023
-
Abstract
- Competing Interests: Conflicts of interest None disclosed.
- Subjects :
- Humans
TOR Serine-Threonine Kinases
Neurofibromatoses
Subjects
Details
- Language :
- English
- ISSN :
- 1097-6787
- Volume :
- 88
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Journal of the American Academy of Dermatology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 36858154
- Full Text :
- https://doi.org/10.1016/j.jaad.2023.02.032